The weekly litigation news digest is live. Subscribe now

James Poole competitive analysis

Explore patent oppositions filed by James Poole against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 15, 2026
Patent NumberTitleApplicantOpposition Date
Combinatorial Dna ScreeningMYRIAD WOMENS HEALTHDec 4, 2025
Novel Synthesis Of Salcaprozic Acid By Amide FormationNOVO NORDISKOct 28, 2025
Compositions And Methods For Quantifying A Nucleic Acid Sequence In A SampleENVIROLOGIXAug 6, 2025
Methods For Improving Safety Of Blood-Brain Barrier TransportF HOFFMANN LA ROCHEJul 16, 2025
Proteomic Sample Preparation Using Paramagnetic BeadsEUROPEAN MOLECULAR BIOLOGY LABORATORYJul 9, 2025
"Chimeric Molecules And Uses Thereof"THE UNIVERSITY OF QUEENSLANDMay 14, 2025
Charged Depth Filtration Of Antigen-Binding ProteinsAMGENMay 2, 2025
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYFeb 14, 2025
Novel Crispr Enzymes And SystemsMASSACHUSETTS INSTITUTE OF TECHNOLOGYFeb 3, 2025
Detection Of Colorectal CancerUNIVERSAL DIAGNOSTICSJan 17, 2025

Latest PTAB cases involving James Poole

Discover the latest PTAB cases involving James Poole, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing James Poole with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 15, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JAMES POOLE155 - - -
AMGEN8138811
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - 75 - 16
PRESIDENT AND FELLOWS OF HARVARD COLLEGE - 86 - 8